SLC31A2 and acute myeloid leukemia: Additionally, we analyzed the expression levels of these genes in AML and normal samples from the TCGA and GTEx databases and found that, aside from the lower expression of SLC31A2 in normal samples, there were no significant differences in other genes between AML and normal samples (Figure S6A–F).